• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Eur J Emerg Med . Incidence, risk factors, clinical characteristics and outcomes of deep venous thrombosis in patients with COVID-19 attending the

tetano

Editor, Senior Moderator
Eur J Emerg Med


. 2021 Jun 1;28(3):218-226.
doi: 10.1097/MEJ.0000000000000783.
Incidence, risk factors, clinical characteristics and outcomes of deep venous thrombosis in patients with COVID-19 attending the Emergency Department: results of the UMC-19-S8


S?nia Jim?nez[SUP] 1 [/SUP], ?scar Mir?[SUP] 1 [/SUP], Pere Llorens[SUP] 2 [/SUP], Francisco J Mart?n-S?nchez[SUP] 3 [/SUP], Guillermo Burillo-Putze[SUP] 4 [/SUP], Pascual Pi?era[SUP] 5 [/SUP], Alfonso Mart?n[SUP] 6 [/SUP], Aitor Alqu?zar[SUP] 7 [/SUP], Eric J Garc?a-Lamberechts[SUP] 3 [/SUP], Javier Jacob[SUP] 8 [/SUP], Mar?a L L Grima[SUP] 9 [/SUP], Javier Mill?n[SUP] 10 [/SUP], Francisca Molina[SUP] 11 [/SUP], Patricia B Albero[SUP] 12 [/SUP], Carlos Cardozo[SUP] 1 13 [/SUP], Josep M M?dol[SUP] 14 [/SUP], Alfons Aguirre[SUP] 15 [/SUP], Ruth Gaya[SUP] 16 [/SUP], Mar?a Adroher[SUP] 17 [/SUP], Llu?s Llauger[SUP] 18 [/SUP], Juan J L D?az[SUP] 19 [/SUP], Nayra C Gonz?lez[SUP] 20 [/SUP], Paula L Arag?es[SUP] 5 [/SUP], Ana P G?mez[SUP] 21 [/SUP], Juan G Del Castillo[SUP] 3 [/SUP], Spanish Investigators on Emergency Situations TeAm (SIESTA) network



Affiliations

Abstract

Background and importance: A higher incidence of venous thromboembolism [both pulmonary embolism and deep vein thrombosis (DVT)] in patients with coronavirus disease 2019 (COVID-19) has been described. But little is known about the true frequency of DVT in patients who attend emergency department (ED) and are diagnosed with COVID-19.
Objective: We investigated the incidence, risk factors, clinical characteristics and outcomes of DVT in patients with COVID-19 attending the ED before hospitalization.
Methods: We retrospectively reviewed all COVID patients diagnosed with DVT in 62 Spanish EDs (20% of Spanish EDs, case group) during the first 2 months of the COVID-19 outbreak. We compared DVT-COVID-19 patients with COVID-19 without DVT patients (control group). Relative frequencies of DVT were estimated in COVID and non-COVID patients visiting the ED and annual standardized incidences were estimated for both populations. Sixty-three patient characteristics and four outcomes were compared between cases and controls.
Results: We identified 112 DVT in 74 814 patients with COVID-19 attending the ED [1.50?; 95% confidence interval (CI), 1.23-1.80?]. This relative frequency was similar than that observed in non-COVID patients [2109/1 388 879; 1.52?; 95% CI, 1.45-1.69?; odds ratio (OR) = 0.98 [0.82-1.19]. Standardized incidence of DVT was higher in COVID patients (98,38 versus 42,93/100,000/year; OR, 2.20; 95% CI, 2.03-2.38). In COVID patients, the clinical characteristics associated with a higher risk of presenting DVT were older age and having a history of venous thromboembolism, recent surgery/immobilization and hypertension; chest pain and desaturation at ED arrival and some analytical disturbances were also more frequently seen, d-dimer >5000 ng/mL being the strongest. After adjustment for age and sex, hospitalization, ICU admission and prolonged hospitalization were more frequent in cases than controls, whereas mortality was similar (OR, 1.37; 95% CI, 0.77-2.45).
Conclusions: DVT was an unusual form of COVID presentation in COVID patients but was associated with a worse prognosis.
 
Back
Top Bottom